RT @kamleshkhunti: Registered clinical trials for #COVID-19-China & USA account for 87.6% of the studies! Many unlikely to have scientific…

Registered clinical trials for #COVID-19-China & USA account for 87.6% of the studies! Many unlikely to have scientific value? https://t.co/XeZeFKT0hk https://t.co/QqFkkuuTyD

RT @NaudetFlorian: Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis | BMJ Open h…

RT @pmanickam: Clinical trials for #COVID19 Total=201 92 drugs or plasma, incl 64 in monotherapy & 28 combinations 8 products or combinatio…

RT @pmanickam: Clinical trials for #COVID19 Total=201 92 drugs or plasma, incl 64 in monotherapy & 28 combinations 8 products or combinatio…

RT @RetractionWatch: "While accelerating morbidity and mortality from the COVID-19 pandemic has been paralleled by early and rapid clinical…

Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis | BMJ Open https://t.co/CvAibAOV4C

"While accelerating morbidity and mortality from the COVID-19 pandemic has been paralleled by early and rapid clinical investigation, many trials lack features to optimize their scientific value." https://t.co/GkEGGByTat

Characteristics of registered clinical trials assessing treatments for #COVID-19: a cross-sectional analysis https://t.co/laGKJ0NVAG

Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis | BMJ Open https://t.co/ur6KFZxaTT

Many COVID trials are poorly designed: Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis https://t.co/8vtofKAPqv via @BMJ_Open

Så lærte vi også, at vi globalt set er ret dårlige til at sætte gode kliniske studier op i en fart, når vi møder en pandemi som #Covid_19. https://t.co/QXYu3OZUVK https://t.co/GuKyscorDG

Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis https://t.co/JomxxEk3IJ

COVID 19 Data—we asked for it. We got it. But was it very good? Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis https://t.co/0gUEwcn4ju

Pour ceux qui parlaient de "French protocol" pour parler de protocole méthodiquement peu rigoureux. Sachez que ce n'était pas une spécificité française. (C'est juste que certains savent faire plus de bruit que d'autres) https://t.co/qLc8MNfNNo

RT @RetractionWatch: "While accelerating morbidity and mortality from the #COVID-19 pandemic has been paralleled by early and rapid clinica…

RT @RetractionWatch: "While accelerating morbidity and mortality from the #COVID-19 pandemic has been paralleled by early and rapid clinica…

RT @mehtahemal: Majority of First-Wave COVID-19 Clinical Trials Have Significant Design Shortcomings. https://t.co/csvNTEGXex https://t.…

Nice work Hemal!

RT @RetractionWatch: "While accelerating morbidity and mortality from the #COVID-19 pandemic has been paralleled by early and rapid clinica…

Majority of First-Wave COVID-19 Clinical Trials Have Significant Design Shortcomings. https://t.co/csvNTEGXex https://t.co/dajEtNu2Jn

RT @RetractionWatch: "While accelerating morbidity and mortality from the #COVID-19 pandemic has been paralleled by early and rapid clinica…

RT @RetractionWatch: "While accelerating morbidity and mortality from the #COVID-19 pandemic has been paralleled by early and rapid clinica…

RT @RetractionWatch: "While accelerating morbidity and mortality from the #COVID-19 pandemic has been paralleled by early and rapid clinica…

"While accelerating morbidity and mortality from the #COVID-19 pandemic has been paralleled by early and rapid clinical investigation, many trials lack features to optimise their scientific value." @mehtahemal et al in @BMJ_Open. https://t.co/GkEGGByTat